Massimo Group Announces Bitcoin Treasury Strategy
GARLAND, Texas, Dec. 1, 2025 /PRNewswire/ — Massimo Group (NASDAQ: MAMO) today announced that its Board of Directors has approved the inclusion of Bitcoin... Read more.
Commvault Achieves AWS Resilience Competency Status
Delivers validated expertise in helping customers strengthen cyber resilience and recovery across AWS and hybrid-cloud environments TINTON FALLS, N.J., Dec. 1,... Read more.
Kurv Rolls Out All-in-One Kurv Merchant App and Tap to Pay on Android Feature
CLEVELAND, Dec. 1, 2025 /PRNewswire/ — Kurv, formerly known as Electronic Merchant Systems, announced today its all-in-one Kurv Merchant App, complete with... Read more.
BitMine Immersion (BMNR) Announces ETH Holdings Reach 3.73 Million Tokens, and Total Crypto and Cash Holdings of $12.1 Billion
BitMine now owns more than 3.0% of the ETH token supply, two-thirds of the way to the ‘Alchemy of 5%’ BitMine Crypto + Cash Holdings + “Moonshots”... Read more.
Fathom Holdings Divests LiveBy Assets to Move Concierge
Fathom to Receive $3.0 Million Cash CARY, N.C., Dec. 1, 2025 /PRNewswire/ — Fathom Holdings Inc. (Nasdaq: FTHM) (“Fathom” or the “Company”), a... Read more.
JPIX Selects XKL for IX Network Infrastructure Upgrade
JPIX Extends 400G Network Infrastructure with XKL’s DWDM Technology REDMOND, Wash., Dec. 1, 2025 /PRNewswire/ — Japan Internet Xing Co., Ltd. (Head Office:... Read more.
Opera browsers now ship with a new generation of AI powered by Google
OSLO, Norway, Dec. 1, 2025 /PRNewswire/ — The browser innovator and agentic AI company Opera (NASDAQ: OPRA) is rolling out new AI capabilities across its... Read more.
YY Group Secures 3-Year Facility Maintenance Contract with a Major International Bank
New Partnership Broadens Client Base and Enhances Business Quality with Stable, Long-Term Revenue SINGAPORE, Dec. 1, 2025 /PRNewswire/ — YY Group Holding Limited... Read more.
Galmed Issues CEO Letter to Shareholders
TEL AVIV, Israel, Dec. 1, 2025 /PRNewswire/ — Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage... Read more.
Spinogenix Announces World Health Organization Approval of ‘tazbentetol’ as International Non-Proprietary Name for SPG302
Tazbentetol is a First-in-Class, Synaptic Regenerative Investigation Therapy for Alzheimer’s disease, ALS, Schizophrenia and Glaucoma LOS ANGELES, Dec. 1,... Read more.